Prostanoid receptor expression in colorectal cancer related to tumor stage, differentiation and progression

References

• Cahlin C, Gelin J, Andersson M, Lonnroth C, Lundholm K. The effects of non-selective, preferential-selective and selective COX-inhibitors on the growth of experimental and human tumors in mice related to prostanoid receptors. Int J Oncol 2005; 27: 913–23
   PubMed Web of Science ®Google Scholar
• Gelin J, Andersson C, Lundholm K. Effects of indomethacin, cytokines, and cyclosporin A on tumor growth and the subsequent development of cancer cachexia. Cancer Res 1991; 51: 880–5
   PubMed Web of Science ®Google Scholar
• Cao Y Prescott SM Many actions of Cyclooxygenase-2 in cellular dynamics and in cancer. J Cell Physiol 2002;190:276–86.
   Google Scholar
• Pradono P, Tazawa R, Maemondo M, Tanaka M, Usui K, Saijo Y, et al. Gene transfer of thromboxane A(2) synthase and prostaglandin I(2) synthase antithetically altered tumor angiogenesis and tumor growth. Cancer Res 2002; 62: 63–6
   PubMed Web of Science ®Google Scholar
• Wang D, Dubois RN. Prostaglandins and cancer. Gut 2006; 55: 115–22
   PubMed Web of Science ®Google Scholar
• Hull MA, Ko SC, Hawcroft G. Prostaglandin EP receptors: Targets for treatment and prevention of colorectal cancer?. Mol Cancer Ther 2004; 3: 1031–9
   PubMed Web of Science ®Google Scholar
• Kune GA, Kune S, Watson LF. Colorectal cancer risk, chronic illnesses, operations, and medications: Case control results from the Melbourne Colorectal Cancer Study. Cancer Res 1988; 48: 4399–404
   PubMed Web of Science ®Google Scholar
• Thun MJ, Namboodiri MM, Calle EE, Flanders WD, Heath CW, Jr. Aspirin use and risk of fatal cancer. Cancer Res 1993; 53: 1322–7
   PubMed Web of Science ®Google Scholar
• Muscat JE, Stellman SD, Wynder EL. Nonsteroidal antiinflammatory drugs and colorectal cancer. Cancer 1994; 74: 1847–54
   PubMed Web of Science ®Google Scholar
• Sandler RS, Halabi S, Baron JA, Budinger S, Paskett E, Keresztes R, et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 2003; 348: 883–90
   PubMed Web of Science ®Google Scholar
• Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: Structures, properties, and functions. Physiol Rev 1999; 79: 1193–226
   PubMed Web of Science ®Google Scholar
• Yang VW, Shields JM, Hamilton SR, Spannhake EW, Hubbard WC, Hylind LM, et al. Size-dependent increase in prostanoid levels in adenomas of patients with familial adenomatous polyposis. Cancer Res 1998; 58: 1750–3
   PubMed Web of Science ®Google Scholar
• Rigas B, Goldman IS, Levine L. Altered eicosanoid levels in human colon cancer. J Lab Clin Med 1993; 122: 518–23
   PubMed Web of Science ®Google Scholar
• Pinto S, Gori L, Gallo O, Boccuzzi S, Paniccia R, Abbate R. Increased thromboxane A2 production at primary tumor site in metastasizing squamous cell carcinoma of the larynx. Prostaglandins Leukot Essent Fatty Acids 1993; 49: 527–30
   PubMed Web of Science ®Google Scholar
• Ushikubi F, Sugimoto Y, Ichikawa A, Narumiya S. Roles of prostanoids revealed from studies using mice lacking specific prostanoid receptors. Jpn J Pharmacol 2000; 83: 279–85
   PubMedGoogle Scholar
• Fulton AM, Ma X, Kundu N. Targeting prostaglandin E EP receptors to inhibit metastasis. Cancer Res 2006; 66: 9794–7
   PubMed Web of Science ®Google Scholar
• Gustafsson A, Hansson E, Kressner U, Nordgren S, Andersson M Wang W, et al. EP1-4 subtype, COX and PPARgamma receptor expression in colorectal cancer in prediction of disease-specific mortality. Int J Cancer 2007;121:232–40.
   PubMed Web of Science ®Google Scholar
• Thun MJ, Namboodiri MM, Heath CW, Jr. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 1991; 325: 1593–6
   PubMed Web of Science ®Google Scholar
• Cahlin C, Lönnroth C, Arvidsson A, Nordgren S, Lundholm K. Growth associated proteins in tumor cells and stroma related to disease progression of colorectal cancer accounting for tumor tissue PGE2 content. Brit J Surg (submitted 2007).
   Google Scholar
• Lönnroth C, Andersson M, Arvidsson A, Nordgren S, Brevinge H. Lundholm K Preoperative treatment with NSAID increased tumor tissue infiltration of activated immune cells in colorectal cancer. Submitted 2007.
   Google Scholar
• Hirai H, Tanaka K, Takano S, Ichimasa M, Nakamura M, Nagata K. Cutting edge: agonistic effect of indomethacin on a prostaglandin D2 receptor, CRTH2. J Immunol 2002; 168: 981–5
   PubMed Web of Science ®Google Scholar
• Gosset P, Bureau F, Angeli V, Pichavant M, Faveeuw C, Tonnel AB, et al. Prostaglandin D2 affects the maturation of human monocyte-derived dendritic cells: Consequence on the polarization of naive Th cells. J Immunol 2003; 170: 4943–52
   PubMed Web of Science ®Google Scholar
• Fujino H, Regan JW. Prostanoid receptors and phosphatidylinositol 3-kinase: A pathway to cancer?. Trends Pharmacol Sci 2003; 24: 335–40
   PubMed Web of Science ®Google Scholar
• Sales KJ, Milne SA, Williams AR, Anderson RA, Jabbour HN. Expression, localization, and signaling of prostaglandin F2 alpha receptor in human endometrial adenocarcinoma: regulation of proliferation by activation of the epidermal growth factor receptor and mitogen-activated protein kinase signaling pathways. J Clin Endocrinol Metab 2004; 89: 986–93
   PubMed Web of Science ®Google Scholar
• Nie D, Lamberti M, Zacharek A, Li L, Szekeres K, Tang K, et al. Thromboxane A(2) regulation of endothelial cell migration, angiogenesis, and tumor metastasis. Biochem Biophys Res Commun 2000; 267: 245–51
   PubMed Web of Science ®Google Scholar
• Yoshimura-Uchiyama C, Iikura M, Yamaguchi M, Nagase H, Ishii A, Matsushima K, et al. Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2. Clin Exp Allergy 2004; 34: 1283–90
   PubMed Web of Science ®Google Scholar
• Yoshida T, Ohki S, Kanazawa M, Mizunuma H, Kikuchi Y, Satoh H, et al. Inhibitory effects of prostaglandin D2 against the proliferation of human colon cancer cell lines and hepatic metastasis from colorectal cancer. Surg Today 1998; 28: 740–5
   PubMed Web of Science ®Google Scholar
• Hawcroft G, Gardner SH, Hull MA. Expression of prostaglandin D2 receptors DP1 and DP2 by human colorectal cancer cells. Cancer Lett 2004; 210: 81–4
   PubMed Web of Science ®Google Scholar